Spondylitis News and Research

RSS
Arthritis drug wins approval for use in children with Crohn's disease

Arthritis drug wins approval for use in children with Crohn's disease

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Pfizer adds warning to Celebrex arthritis drug

Pfizer adds warning to Celebrex arthritis drug

Spinal arthritis often overlooked in children

Spinal arthritis often overlooked in children

Arthritis patients still suffer as drugs guidelines are ignored

Arthritis patients still suffer as drugs guidelines are ignored

Study suggests continuous NSAID treatment more effectively reduces X-Ray progression than intermittent treatment

Study suggests continuous NSAID treatment more effectively reduces X-Ray progression than intermittent treatment

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

500,000 patients have now been treated with REMICADE® worldwide

500,000 patients have now been treated with REMICADE® worldwide

Coronary stent drives Johnson & Johnson to record profits

Coronary stent drives Johnson & Johnson to record profits

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis